Mareca Pallister, MD
Obstetrics & Gynecology · Windsor, VTNPI 1568489920
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.9% of the total across 17 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 8 manufacturers, the largest accounting for just 21.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $138 and has fallen 81.4% since, to $26 in 2025.
Across 17 payments — averaging $26.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bayer$93
- AbbVie$87
- Astellas Pharma US Inc$81
- Amgen$70
- Myriad Genetic Laboratories, Inc.$67
- AMAG Pharmaceuticals, Inc.$18
- plus $27 from 2 others
What the payments were for
- Food & beverage$42596%
- Education$184%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bayer | 4 | $93 |
| AbbVie | 4 | $87 |
| Astellas Pharma US Inc | 4 | $81 |
| Amgen | 1 | $70 |
| Myriad Genetic Laboratories, Inc. | 1 | $67 |
| AMAG Pharmaceuticals, Inc. | 1 | $18 |
| Coopersurgical, Inc. | 1 | $15 |
| Organon | 1 | $12 |
How this compares
$444 in reported general payments places this provider in the 85th percentile of 74 obstetrics & gynecology providers in Vermont.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 73 | $6,378 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Windsor
- Lauren MacafeeBurlington$24K
- Hannah NorthBrattleboro$6K
- Rachel LongBerlin$3K
- Kira BalkcomRutland$1K
- Catherine BonifaceBurlington$1K
- Stephen BrownBurlington$1K
- Navin Maredia EbrahimiBurlington$1K
- Merima RuhotinaBurlington$1K
- Jennifer WetheraldSt Johnsbury$793
- Kathryn LeopoldSouth Burlington$413
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.